Home・Stock List・Medpace Holdings Inc

Medpace Holdings Inc

Closed

SectorHealthcare

611.43 15.68

Buy Sell

Overview

Share price change

24h

Current

Min

522.3

Max

535.76

Key metrics
By Trading Economics
Income	-11M 124M
Sales	-1.8M 707M
P/E Sector Avg	33.224 62.58
EPS	4.28
Profit margin	17.53
Employees	6,300
EBITDA	-9.5M 154M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	-6.84% downside

Dividends
By Acuity
Next Earnings	21 Oct 2026

Market Stats
By TradingEconomics
Market Cap	-14M 15B
Previous open	595.75
Previous close	611.43

News Sentiment

By Acuity

57%

43%

275 / 340 Healthcare

Medpace Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

22 Jul 2026, 23:22 UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 Jul 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Peer Comparison

Price change

Medpace Holdings Inc Forecast

Price Target

By TipRanks

-6.84% downside

12 Months Forecast

Average 492 USD -6.84%

High 586 USD

Low 400 USD

Based on 8 Wall Street analysts offering 12 month price targets forMedpace Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Medpace Holdings Inc - Dist in the past 3 months.

Sentiment

By Acuity

275 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.